CoChat

The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction

Open access
Newman, Jonathan D., Vani, Anish K., Aleman, Jose O., Weintraub, Howard S., Berger, Jeffrey S., Schwartzbard, Arthur Z. · 2018 · Journal of the American College of Cardiology
Cited by 93

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

Type 2 diabetes mellitus (T2D) is a major risk factor for cardiovascular disease (CVD), the most common cause of death in T2D. Despite improved risk factor control, however, adults with T2D continue to experience substantial excess CVD risk. Until recently, however, improved glycemic control has not been associated with robust macrovascular benefit. The advent of two new classes of anti-hyperglycemic agents, the sodium-glucose cotransporter-2 inhibitors (SGLT2-i) and the glucagon-like peptide-1 receptor agonists (GLP-1 RA), and their respective large cardiovascular outcome trials, has led to a paradigm shift in how cardiologists and heath care practitioners conceptualize T2D treatment. Herein we will review the recent trial evidence, the potential mechanisms of action of SGLT2-i and GLP-1 RA, safety concerns, and their use for the primary prevention of CVD as well as in diabetics with impaired renal function and heart failure.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2018.07.071

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Cited by

See all 93

Metadata

Authors
Newman, J. D., Vani, A. K., Aleman, J. O., Weintraub, H. S., Berger, J. S., & Schwartzbard, A. Z.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2018-10
Volume
72
Issue
15
Pages
1856-1869
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2894567505
Cited by
93
References
49
FWCI
7.16
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction. https://app.cochat.ai/papers/10.1016/j.jacc.2018.07.071
The paper
Newman, J. D., Vani, A. K., Aleman, J. O., Weintraub, H. S., Berger, J. S., & Schwartzbard, A. Z. (2018). The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2018.07.071

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.